Lisanti Capital Growth, LLC Charles River Laboratories International, Inc. Transaction History

Lisanti Capital Growth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	SELL	$351.38 - $448.68 $3.11 Million - $3.97 Million	-8,845 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$372.64 - $458.3 $642,804 - $790,567	1,725 Added 24.23%	8,845 $3.65 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $3.2 Million - $4.05 Million	-10,890 Reduced 60.47%	7,120 $2.63 Million
Q1 2021 May 12, 2021	BUY	$249.67 - $299.48 $2.29 Million - $2.75 Million	9,185 Added 104.08%	18,010 $5.22 Million
Q3 2020 Nov 05, 2020	BUY	$175.56 - $226.45 $402,032 - $518,570	2,290 Added 35.04%	8,825 $2 Million
Q2 2020 Aug 10, 2020	BUY	$118.84 - $189.72 $776,619 - $1.24 Million	6,535 New	6,535 $1.14 Million

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.